1 / 36

Evaluating & Managing The Dual Diagnosis Patient

Evaluating & Managing The Dual Diagnosis Patient. Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services Clinical Associate Professor of Psychiatry & Behavioral Sciences Department of Psychiatry & Behavioral Sciences

uyen
Download Presentation

Evaluating & Managing The Dual Diagnosis Patient

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Evaluating & ManagingThe Dual Diagnosis Patient Peter A. DeMaria, Jr.., M.D., FASAM Coordinator of Psychiatric Services Tuttleman Counseling Services Clinical Associate Professor of Psychiatry & Behavioral Sciences Department of Psychiatry & Behavioral Sciences Temple University School of Medicine Philadelphia, Pennsylvania

  2. Case Study A Anne is a 19 year old student who tells you that she has been diagnosed with ADHD, anorexia nervosa, depression, borderline personality disorder and alcoholism. She is prescribed methylphenidate (Concerta), citalopram (Celexa), quetiapine (Seroquel) and alprazolam (Xanax). She recently had a relationship break-up. She feels her depression is getting worse and she has started to drink again. She appears of average height and weight.

  3. Case Study B Brian is a 20 year old student who complains of problems with concentration and focus. He finds that he forgets to do important things; this forgetfulness has caused problems with his schoolwork and in his relationship with his GF. He has a well documented ADHD history and would like to restart his stimulant. He reports that he likes to party with his friends on the weekends and smokes MJ during the week to help him relax and sleep.

  4. Case Study C Bill is a 21 year old student who presents stating that he has mood swings and can’t sleep. He has a history of binge alcohol and cocaine use, but says he hasn’t had any cocaine in a month.

  5. Presenting Psychiatric Symptoms • Anxiety • Depression • Insomnia • Psychotic symptoms • Disruptive behavior

  6. Causes of Psychiatric Symptoms • Drug intoxication or withdrawal states • Medical illness • Psychiatric comorbidity

  7. The Challenge Dual Diagnosis Mental Illness Substance Use Disorder

  8. Definition of Addictive Disease Addiction is a primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by continuous or episodic impaired control over drinking or drug use, preoccupation with alcohol or drugs, use of alcohol or drugs despite adverse consequences, and distortion in thinking, most notably denial. (Adapted from the NCADD and ASAM Definition of Alcoholism.)

  9. Chronic Disease Model • Prototypes: CAD, HTN, DM • Development and course reflect an interplay of genetic vulnerability, pathophysiology, and personal behaviors • Treatment focuses on management not cure • Goals include highest quality of life • Patient must take an active role in treatment • Compliance is frequently an issue

  10. Substance Use Is a Spectrum Disorder Abstinence Experimentation Substance abuse Substance dependence

  11. Lifetime Prevalence of Comorbidity - ECA Date • Mental Disorders, 22.5% • Comorbidity = 29% • Alcohol = 22% • Other drug = 15% • Alcohol Disorder, 13.5% • Comorbidity = 45% • Psychiatric - 37% • Other drug = 22% • Other Drug Disorder = 6.1% • Comorbidity = 72% • Psychiatric = 53% • Alcohol = 47% JAMA 264(19):2511-2518,1990

  12. Epidemiology of Dual Diagnosis • ECA Study: Alcoholics have 1.5 - 2 x higher incidence of depression than general population • Alcoholics: • At intake 70% have moderate to severe depression • 4 - 6 weeks after detox 10-20% had major depression • Psychiatric inpatients at McLean Hospital: 60% of males and 40% of females met criteria for alcohol or drug abuse or dependence

  13. Epidemiology of Dual Diagnosis • Cocaine addicts at McLean Hospital: 27% had affective illness. • Opiate addicts: 54% had lifetime incidence and 24% had current episode of major depression. • 15.2% of respondents in the NCS who had ADHD met criteria for any substance use disorder (3 x the rate of respondents without ADHD).

  14. The Biopsychosocial Spiritual Orientation Biological Spiritual Social Psychological

  15. Biological Genetics Health issues Brain chemistry Social Living unit Relationships Work/school Cultural factors Spiritual Organizing principles Morals/ethics Cultural factors Psychological Self esteem Identity Object relations Drives/defenses/ conflicts Developmental history Trauma/abuse Personality traits Relationships The Biopsychosocial Spiritual Orientation

  16. Dual Diagnosis “Dual diagnosis is an expectation, not an exception.” -Dr. Kenneth Minkoff www.kenminkoff.com

  17. The Four Quadrant Model for Co-Occurring Disorders A guide to treatment planning.

  18. Disorder Parallels

  19. Disorder Parallels

  20. Disorder Parallels

  21. Screening-Assessment-Treatment • High index of suspicion • Screen everyone; revisit regularly • Assess which Stage of Change • Engage in treatment • Use Motivational Interviewing techniques • Use behavioral/contingency contacts • Involve others • Consult/Refer

  22. Stages of Change Precontemplation Contemplation Preparation Action Maintenance

  23. Differentiating Substance Related Disorders from Psychiatric Disorders • Relationship of symptoms to drug use • Which came first? • Presence of symptoms during periods of sobriety • Past treatment history • Atypical presentation • Poor or unpredictable response to treatment • Family history-psychiatric or addiction • Look for common co-morbidities: • Bipolar disorder and alcoholism • ADHD and substance abuse • Cluster B personality traits/disorder

  24. General Approach to the Dual Diagnosis Patient • Comprehensive biopsychosocial spiritual assessment. • Engage patient in treatment and develop a therapeutic relationship. • Develop a treatment plan • Addressing both psychiatric & addiction issues • Assess response • Adjust treatment plan

  25. Treatment Planning • Treatment planning must be individualized. • The treatment plan must follow a careful assessment. • The treatment plan is not static, it is dynamic and changes as the providers learns more and the patient changes with interventions. • Develop a treatment team utilizing the expertise in other clinicians. • Ensure regular and thorough communication between all treatment team members.

  26. Possible Treatment Modalities • Individual counseling/therapy (psychiatric/addiction) • Group counseling/therapy (psychiatric/addiction) • Self-help (12 step) programs • Behavioral/contingency management • Couple’s Therapy • Family therapy • Disability Resources & Services Involvement • IOP/Partial hospitalization • Inpatient psychiatric (dual diagnosis) hospitalization • Psychotropic medication (psychiatric/addiction)

  27. Issues Specific to College MH Practice • Hospitalization necessary/indicated? • Treat in-house or refer out? • Is drug screening available? • Must the student be clean for everything? • If not, what is acceptable? • What support is available on campus?

  28. Pharmacotherapy of Addictive Disorders • Detoxification • Aversive agents • Disulfiram (Antabuse) • Anti-craving Agents • Naltrexone (ReVia, Vivitrol) • Acamprosate (Campral) • Bupropion (Wellbutrin, Zyban) • Varenicline (Chantix)

  29. Pharmacotherapy of Addictive Disorders • Maintenance pharmacotherapy • Nicotine replacement therapy (NRT) • Patch, gum, inhaler, lozenge • Opioid maintenance pharmacotherapy • Methadone • Buprenorphine (Subutex/Suboxone)

  30. General Approach to Psychopharmacology • Use biopsychosocial spiritual model • Avoid addictive substances (e.g. BZ) • Treat psychiatric condition if it prevents engagement in addiction treatment. • Avoid making psychiatric diagnosis and initiating medication until 2-4 weeks into abstinence from substances. • Less is better

  31. Case Study A Anne is a 19 year old student who tells you that she has been diagnosed with ADHD, anorexia nervosa, depression, borderline personality disorder and alcoholism. She is prescribed methylphenidate (Concerta), citalopram (Celexa), quetiapine (Seroquel) and alprazolam (Xanax). She recently had a relationship break-up. She feels her depression is getting worse and she has started to drink again. She appears of average height and weight.

  32. Case Study B Brian is a 20 year old student who complains of problems with concentration and focus. He finds that he forgets to do important things; this forgetfulness has caused problems with his schoolwork and in his relationship with his GF. He has a well documented ADHD history and would like to restart his stimulant. He reports that he likes to party with his friends on the weekends and smokes MJ during the week to help him relax and sleep.

  33. Case Study C Bill is a 21 year old student who presents stating that he has mood swings and can’t sleep. He has a history of binge alcohol and cocaine use, but says he hasn’t had any cocaine in a month.

More Related